Test Location Segment Analysis: OTC (Largest Segment) vs POC (Fastest-Growing Segment)

In the point-of-care molecular diagnostics market, the OTC segment accounted for 55.23% share in 2026, reflecting strong demand for convenient access to diagnostic testing outside traditional clinical settings. Over-the-counter molecular diagnostic solutions can provide users with greater autonomy, reduce dependence on healthcare appointments, and support earlier identification of health conditions. Increasing consumer awareness, preference for convenient testing, and broader acceptance of decentralized diagnostic approaches are supporting the continued prominence of OTC testing.

The POC segment is expanding at the fastest pace as healthcare systems place greater emphasis on rapid diagnosis and decentralized testing. Point-of-care molecular diagnostics enable testing to be conducted closer to the patient, supporting timely clinical decisions and reducing reliance on centralized laboratory workflows. Improvements in assay portability, automation, ease of use, and result delivery are making these technologies increasingly practical across healthcare environments. The growing focus on accessible diagnostics and faster treatment decisions is expected to further encourage adoption of POC molecular testing.

Technology Segment Analysis: PCR-based (Largest Segment) vs Genetic Sequencing-based (Fastest-Growing Segment)

PCR-based technology represented the largest share of the point-of-care molecular diagnostics market, with 64.38% in 2026, owing to its established role in sensitive and specific molecular detection. PCR-based testing is widely applicable across infectious disease and other diagnostic applications, supported by mature workflows, established clinical familiarity, and the ability to detect target genetic material efficiently. Continued demand for dependable molecular testing and the expansion of decentralized diagnostic capabilities are sustaining the technology's strong market position.

Genetic sequencing-based technology is the fastest-growing segment as diagnostic applications increasingly require more detailed molecular information. Sequencing can provide insights into genetic variations and pathogen characteristics that extend beyond conventional target detection, supporting applications where broader genomic analysis is valuable. Advances in sequencing workflows, instrument accessibility, data interpretation, and clinical genomics are helping expand its relevance in point-of-care settings. The increasing emphasis on personalized diagnostics and more comprehensive molecular characterization is further supporting adoption.